Genocea Biosciences Competitors and Similar CompaniesClear all
Genocea Biosciences's competitors and similar companies include Emtora Biosciences, Omeros, HUYA Bioscience International and Deciphera Pharmaceuticals.
 Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. |  Emtora Biosciences Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | |
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 1994 | Founding Date 2004 | Founding Date 2003 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations San Antonio, US HQ | Locations Seattle, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Waltham, US HQ Lawrence, US |
Employees | Employees 593% decrease | Employees 2 | Employees 1968% decrease | Employees 1113% increase | Employees 35037% increase |
Valuation ($) | Valuation ($) 5.7 k | Valuation ($) N/A | Valuation ($) 248.6 m | Valuation ($) N/A | Valuation ($) 2.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $163.4m (FY, 2023) |
Net income | Net income ($33.2m) (FY, 2021) | Net income N/A | Net income ($156.8m) (FY, 2024) | Net income N/A | Net income ($194.9m) (FY, 2023) |
Operating ⚠ | |||||
Patents (Foreign) | Patents (Foreign) N/A | Patents (Foreign) N/A | Patents (Foreign) 1 (FY, 2021) | Patents (Foreign) N/A | Patents (Foreign) 47 (Aug, 2017) |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 80 (FY, 2021) | Patents (US) N/A | Patents (US) 11 (Aug, 2017) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 3m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 7.6m (over 13 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 209.5m | Total funding raised $ 3m | Total funding raised $ 354.8m | Total funding raised $ 12.6m | Total funding raised $ 714m |
For sources of this data, please see the company profile
View Company Profiles
Emtora Biosciences
HQ
San Antonio, US
Employees
2
Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence.
View companyOmeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company